Answers are grounded in this paper and cite their sources.
Tectorigenin, a natural isoflavonoid, exhibits antioxidant and lipid-regulating properties, but its effects on ovine oocyte maturation remain unexplored. This study investigated the impact of tectorigenin supplementation during in vitro maturation (IVM) on cytoplasmic quality, mitochondrial function, lipid homeostasis, and subsequent embryonic development in Tan sheep oocytes. Oocytes were matured with graded tectorigenin concentrations (0, 1, 10, 50 μM). While no significant difference was observed in first polar body extrusion rates among groups, 10 μM tectorigenin markedly improved blastocyst formation rate (37.48% vs. 16.30% in control, p < 0.01). Mechanistically, tectorigenin elevated intracellular glutathione levels, upregulated CAT and SOD2 expression, maintained mitochondrial membrane potential, and modulated apoptosis-related gene expression (BCL2 up, BAX and CASPASE3 down). It also promoted the accumulation of neutral lipid droplets (FASN up, ACC down), accompanied by altered expression of lipid metabolism-related genes. Resulting blastocysts exhibited higher total cell numbers, increased proliferation (EdU-positive cells), and elevated OCT4 and CDX2 expression. However, 50 μM tectorigenin showed no beneficial effect, highlighting dose dependency. Collectively, supplementation with 10 μM tectorigenin is associated with improved cytoplasmic maturation-related indicators in oocytes, as evidenced by increased GSH reserves, maintained mitochondrial membrane potential, and altered transcription of apoptosis- and lipid metabolism-related genes, which corresponds to enhanced subsequent embryonic developmental competence.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: